## Summary
The paper introduces Earliest Disagreement Q-Evaluation (EDQ), an off-policy evaluation method for marked decision point processes that estimates the causal effect of policies intervening on both *when* and *what* to treat in continuous, irregular time. The key theoretical contribution (Theorem 1) is a tower-property recursion expressed over earliest-disagreement times between observed and target intensities, which yields a model-free, importance-weight-free, discretization-free dynamic programming estimator implementable with a GPT-2 backbone. EDQ is validated on two simulators (time-to-failure and tumor growth) against ERM/MC and a self-implemented discrete-time FQE.

## Strengths
- **Clean and well-motivated theoretical reformulation.** Theorem 1 and Eq. (3) give a recursion over the earliest disagreement time between the observed and target intensities. Because point processes have countably many decision points, this sidesteps both fine discretization and importance weighting and naturally inherits sequence-model architectures.
- **Careful treatment of continuous-time identification.** Section 2.2 explicitly grounds identifiability in the Røysland et al. local-independence / eliminability framework, including a stated ignorability assumption (Assumption 1) and overlap (Assumption 2). Corollary 1 ties the regression target to a causal effect, which is rare in ML treatments of continuous-time OPE.
- **Concrete instantiation with modern architectures.** Section 5 details a GPT-2 implementation with continuous-time positional embeddings and target-network updates, showing the method plugs into standard sequence-modeling infrastructure rather than being tied to ODE solvers (a known limitation of TE-CDE).
- **Useful taxonomy in Section 4.1 / Table 1** clarifying which existing approaches (CRN, CT, R-MSN, TE-CDE, G-Net, CGP, FQE) can or cannot handle dynamic policies plus irregular times.

## Weaknesses

### Fatal
None. The theoretical contribution is sound under stated assumptions and the empirical results, while limited, support a weaker version of the claim than the abstract states.

### Major
- **The headline claim of "advantage relative to baselines that rely on discretization" is not adequately tested.** Section 5.1 explicitly states "we are unaware of baselines" and compares only to (i) ERM/MC and (ii) a discrete-time FQE the authors themselves implement using EDQ's own GPT-2 backbone. Yet Table 1 enumerates G-Net, TE-CDE, R-MSN, CRN, CT, CGP — several of which (G-Net, TE-CDE, Vanderschueren et al.) are precisely defined on the tumor-growth simulator used here. Comparing only against one's own ablation in the regime the paper positions itself against substantially weakens the empirical contribution.
- **The FQE baseline result is suspicious in the on-policy regime, which is where the discretization narrative is supposed to be tested.** In Figure 3 (right), at λ_obs = λ_int = 0.5, FQE achieves 0.197 vs. EDQ's 0.10 — i.e., FQE is roughly 2× worse *on-policy* with the same architecture and dataset, where discretization should impose at most modest information loss. The paper attributes this to "noisy gradient signals" from one-step backups (Section 5.2), but this is exactly what n-step returns, target-network updates, and tuned learning rates address. Without showing that a properly tuned FQE still loses, the "discretization is the problem" story is conflated with "the baseline was undertuned."
- **The identifiability assumptions are stated but never stressed.** The eliminability graph (Fig. 2) and the mutual-independence-of-increments clause in Assumption 1 are strong and non-trivial in the healthcare scenarios the introduction motivates (vitals and treatments routinely co-occur). The two simulators are not designed to probe what happens when these conditions are violated or near-violated, so the empirical work cannot speak to the robustness of the theory.

### Minor
- **The simulators have inductive biases matched to the method.** The time-to-failure simulator is a 1-D scalar vital with linear drift, monotone treatment efficacy, and exponential treatment timing — i.e., a setting where "earliest disagreement" gives the natural scale. On the more realistic tumor-growth simulator with matched policies ((γ,β)=(6,0.75): ERM 0.034 vs. EDQ 0.037; λ_int=λ_obs=0.2: ERM 0.17 vs. EDQ 0.178), the gains from EDQ's machinery shrink to near-tie with ERM, suggesting the advantage attenuates as dynamics become more realistic.
- **No real-data evaluation.** The introduction motivates with cardiology and ASCVD risk; the experiments stay entirely in simulation. The abstract's framing of EDQ as a tool for healthcare decision support is thus a claim about engineering plausibility, not clinical utility. Section 6 acknowledges this as future work.
- **Number of seeds underlying the ±std is never stated.** Reported gaps such as FQE 0.197 vs. EDQ 0.10 cannot be assessed against seed variance.
- **Theorem 1 prose vs. statement.** As written, Theorem 1 invokes only Assumption 2 (overlap) and is essentially a measure-theoretic rewrite; the causal-effect identification rides on Corollary 1 plus Assumption 1. Sharpening this in the main text would prevent readers from over-reading Theorem 1 as a causal-identification result.
- **Algorithm 2 line 6 is dense.** Sampling from the augmented process P̃ and assembling H'_{t+δ} involves several subtleties (which events of the alternative trajectory are kept, how the target intensity is rolled forward against observed x, y). A worked trace would help readers and reviewers verify the construction.

### Trivial
- The computational complexity claim "similar to FQE" is not quantified — a wall-clock or per-iteration count for the two methods on the actual experiments would suffice.

## Nice-to-Haves
- A properly tuned FQE baseline including n-step returns, target-network update tuning, and learning-rate sweeps, with on-policy performance close to ERM as a sanity check, so that the discretization claim can be isolated from optimization issues.
- At minimum a G-Net comparison on tumor growth (it appears in the paper's own Table 1 and operates on this benchmark), and ideally TE-CDE.
- A controlled experiment that violates the eliminability/Fig. 2 graph (e.g., a hidden confounder, or near-simultaneous x and a events) to show how EDQ's bias tracks the theoretical assumptions.
- Variance behavior of EDQ as a function of how often λ_obs and λ disagree (the λ ≫ λ_obs limit collapses EDQ toward first-interval reweighting and deserves discussion).
- A real-data demonstration of the kind the introduction motivates (e.g., MIMIC).

## Removed Points
*These points were raised by the harsh critic but are removed or weakened. Treat with caution.*

- "FQE is undertuned, therefore the discretization claim collapses." Kept as a major weakness in attenuated form, but the strong version ("most likely a tuning artifact") is speculative — the harsh critic cannot prove the FQE was undertuned without running it. The paper does owe a more careful FQE, but calling the result fabricated overshoots.
- "The DP/balancing-rep/prop-weights distinction in Table 1 conflates axes." This is a presentation nitpick rather than a substantive flaw; the table is qualitative and the prose distinguishes the axes adequately.
- Strength: "Scalable model-free implementation with transformers." Kept, since it is grounded in Section 5's concrete architecture description rather than a generic claim.
- Strength: "Clear experimental demonstration under distribution shift." Partially kept inside the strength list; the most-impressive number (RMSE 0.11 vs. 0.28/0.31 at λ_obs=0.1, λ_int=0.5) is real but conditioned on the FQE-tuning caveat, so it is not promoted as a top strength.

## Novel Insights
None beyond the paper's own contributions. The earliest-disagreement recursion is itself the novel observation, and the consolidated review does not surface insights beyond restating what the paper already argues.

## Suggestions
- Add G-Net (and ideally TE-CDE) on the tumor-growth simulator using publicly available implementations, and report seed counts and a tuning protocol for every baseline.
- Re-run FQE with at least n-step returns and target-network tuning, and verify that on-policy FQE matches ERM within seed noise before drawing conclusions about discretization.
- Sharpen the statement of Theorem 1 to make explicit that the causal interpretation flows from Corollary 1 plus Assumption 1, not from Theorem 1 alone.
- Provide a worked numerical example of one EDQ trajectory construction (Algorithm 2, line 6).
- Add at least one experiment that violates the eliminability graph to map theory to empirical robustness.
- Disclose seed counts, total compute, and per-iteration runtime for EDQ vs. FQE.

## Overall Assessment
- **Originality:** Moderate-to-high. Recasting FQE around earliest-disagreement times in a marked point process is a clean and, to my knowledge, novel reformulation; the connection to Røysland's local-independence framework is unusually careful for an ML paper.
- **Importance:** The research question (OPE for irregular-time treatment timing with high-capacity sequence models) is genuinely important and underserved by current methods.
- **Soundness of claims:** Theoretical claims are well supported under stated assumptions. The headline empirical claim — advantage over discretization-based and prior continuous-time methods — is only partially supported because none of the prior continuous-time methods are actually benchmarked and the FQE comparison has internal red flags.
- **Soundness of experiments:** Limited. Two simulators, no real data, no comparison with the most relevant published baselines, no seed counts disclosed.
- **Clarity:** Generally good; Section 2.2 packs in a lot of identifiability machinery but the prose guides the reader. Algorithm 2 line 6 is the densest point.
- **Value to the community:** Real — the recursion is the kind of clean idea practitioners and theorists can build on, even though the empirical case is incomplete.

## Calibration
Anchors retrieved and their fit:
- `aN57tSd5Us.md` (6.25, Stabilized Neural Prediction in Continuous Time): similar topic (irregular timestamps, treatment effects), better empirical scope — paper under review is weaker on baselines.
- `uwO71a8wET.md` (6.50, Bayesian NCDE for treatment effects): similar topic, comparable theoretical care but stronger empirical comparison — paper under review is weaker.
- `0mtz0pet1z.md` (5.75, Incremental Causal Effect for Time to Treatment Initialization): closest topical/structural match (timing-dependent causal effects, theoretically motivated, moderate experiments) — paper under review sits near this anchor but with weaker baselines.
- `mUbYof5MKp.md` (6.00, OPE with partially-observed reward): general OPE accept, more empirically thorough.
- `jZffxvubJ9.md` (3.50, Treatment Rule Optimization under counterfactual TPPs): closest "low" anchor — proposes identifiability theory for TPPs, weak baselines and limited validation. Paper under review is *better* than this: tighter theory, working implementation, and at least clean experiments, but shares the missing-baselines problem.
- `N134PpnlKs.md` (4.00, Twinned Interventional Flows): irregular sampling, hidden confounding, incomplete baselines — comparable failure mode but the paper under review has a sharper theoretical core.
- `lUYY2qsRTI.md` (7.50, Delphic Offline RL): high anchor; cleanly validated on sepsis, much stronger empirics — paper under review does not reach this band.
- `UWdPsY7agk.md` (6.50, Efficient causal decision with one-sided feedback): high anchor with semiparametric guarantees and concrete benchmarks.
- `ZFMiHfZwIf.md` (6.25, Skill or Luck): high anchor, advantage functions for OPE without importance sampling — comparable theory clarity but better empirical breadth.
- `8zJevzvk64.md` (3.50, Schrodinger Bridge OPE): low anchor; suffers from impracticality. Paper under review is well above this — EDQ has a clean usable algorithm.
- `5AJ8R4z5g0.md` (3.25, Potential Outcomes under Hidden Confounders): low anchor; inconsistent methodology. Paper under review is clearly above.
- `RofgmKmk5n.md` (5.50, TPP-LLM): medium anchor; novel pairing but limited evaluation — comparable spot to paper under review.

The paper sits below the >=6 anchors (which have meaningful real-data or strong-baseline empirics) and clearly above the <=4 anchors (which have weak or unusable methodology). It sits closest to `0mtz0pet1z` (5.75), `RofgmKmk5n` (5.50), and slightly above `N134PpnlKs` (4.00) — i.e., borderline with the theoretical contribution holding up the empirical shortfall.

MY FINAL SCORE: <pineapple>5.0</pineapple>
MY FINAL DECISION: <orange>Reject</orange>